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INTRODUCTION 
Entomopathogenic fungi (henceforth EF) are 
group of fungi that parasite insects, and thus are 
able to kill or seriously disable them. During the 
infection to insects, these fungi grow either in the 
inside of insects body or on the exoskeleton surface, 
causing the death of the host insect, which they 
differentiate to form fruiting bodies afterward (Lee, 
Kinoshita, Ihara, Igarashi, & Nihira, 2008). Several 
reports, however, showed that this group of fungi 
posses the significant additional roles in nature. 
The roles includes plant disease antagonists, fungal 
endophytes, rhizosphere colonizers, and plant 
growth promoting agents, or known as PGPF (Plant 
Growth Promoting Fungi). Beauveria bassiana 
(Ascomycota: Hypocreales) and Lecanicillium spp. 
(Ascomycota: Hypocreales) are two well-known EF 
that can function as dual biological control for both 
insect pests and plant pathogens (Ownley, Gwinn, & 
Vega, 2009). The ability of entomopathogenic fungi 
to function as reservoir for natural product resource 
starts to receive wide attention to date. These 
insect fungi now are known to be rich sources of 
structurally novel biolocally active substances.
During infection and proliferation in insects, 
entomopathogenic fungi are thought to produce 
various bioactive compounds, because they need 
to overcome immune defence system of host 
insects and produce toxin to kill the hosts. The 
recent studies on this revealed that these bioactive 
compounds are not only function for fungi defence 
system, but also possess a various beneficial effects 
to human, as it can be functioned as antimicrobial, 
anti-cancer, and/or anti hypercolesterol agents. The 
capability of EF to play role as reservoir for natural 
product resource starts to receive wide attention to 
date.
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ABSTRACT 
Cordyceps militaris is one of entomopathogenic fungi species that is 
well known to be a traditional medicine in China for decades. Although 
the pharmaceutical and/or toxic properties of C. militaris has attracted 
attention as a promising resource for finding bioactive compounds, only 
a few substances including cordycepin have been reported so far. In 
the previous report heterologous expression of LaeA, a global regulator 
for secondary metabolites production in fungi, has been succeeded 
in C. militaris. The LaeA-engineered transformants are proved to 
produce new and/or elevated production of secondary metabolites, 
as detected by HPLC analysis. In order to further characterize the 
secondary metabolites that were being significantly produced by LaeA 
transformant, HPLC profiling and structure elucidation by proton NMR 
were conducted in two target compounds, designated as compound 
1 and compound 2. Compound 1 possessed the highly similar 
characters to insect toxin beauvericin in UV spectrum, molecular 
weight, and retention time in HPLC analysis. Proton NMR analysis 
revealed that compound 1 had the same proton signals as beauvericin.
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The megagenus Cordyceps that is known 
to be highly host specific genus are the most 
notable EF and are objects for significant number 
of researches (Isaka et al., 2005). This genus has 
been commercially used as traditional Chinese 
medicine and is most characterized with respect 
to their bioactive compound production. There are 
several bioactive compounds have been reported 
from Cordyceps, including cordycepin and other 
subtances in the form of adenosine derivatives 
that posses anti-tumour and antibacterial activities 
(Ng & Wang, 2005), an antimalarial agent isolated 
from C.nipponica designated as cordypyridones 
A dan B (Isaka, Tanticharoen, Kongsaeree, & 
Thebtaranonth, 2001).
The fungus C. militaris has raised attention 
recently for the fact that it has notable number of 
biological and pharmacological activities. This 
fungi, also known as north cordyceps, is proved to 
have activities including anticancer, antibacterial, 
antifungal, and immunoregulative activities. The 
extract of these fungi may thus be a potential therapy 
to combat human leukemia (Lee et al., 2006).
Although the pharmaceutical and/or toxic 
properties of C. militaris has attracted attention as a 
promising resource for finding bioactive compounds, 
only a few substances including cordycepin have 
been reported so far. This is possibly due not only 
to the mutual characters among filamentous fungi, 
such as slow growth, but the difficulty to reproduce 
the culture conditions under which EF produce 
bioactive compounds, because EF is considered 
to synthesize various bioactive compounds only 
when it infects or proliferates in the host insects 
but at quite low level under conditions applied in 
laboratories.  To discover newly emerged bioactive 
compounds from this fungus efficiently, the method 
to activate secondary metabolism even under 
laboratory conditions need to be developed.
Despite the fact that these fungi face 
difficulties in producing secondary metabolites, 
the recent reports showed that EF have a notable 
number of secondary metabolism pathways 
that encode potential sources for novel and 
beneficial bioactive compounds. Nevertheless, the 
biosynthetic pathways of the secondary metabolites 
are mostly unknown, possibly due to the fact that 
the productions of the compounds are in trace 
amounts, making it difficult to detect or reproduce. 
An important feature that can facilitate genetic 
analysis of secondary metabolism biosynthesis 
pathways in fungi is the fact that the biosynthetic 
pathway are usually exist in adjacent region and 
form cluster in the genome (Keller, Bok, Chung, 
Perrin, & Shwab, 2006). These biosynthetic gene 
clusters are usually silenced or has an extremely 
low expression resulting in difficulties of production 
under standard culture condition in laboratory 
(Chiang, Lee, Sanchez, Keller, & Wang, 2009).
The expressions of some biosynthetic gene 
clusters known to be regulated by pathway specific 
regulators. However, recent studies revealed that 
histone methylase homolog, namely LaeA, play role 
as a global regulator for the production of secondary 
metabolite in fungi, and regulates the expression 
of various gene clusters in several genera of 
filamentous fungi. LaeA was originally named for 
loss of aflR expression. This methyltransferase 
has S-adenosyl methionine (SAM) binding site 
that is required for several functions (Patananan, 
Palmer, Garvey, Keller, & Clarke, 2013). This global 
regulator has raised attention and become model 
in studying the secondary metabolism in various 
filamentous fungi.
In the previous report (Rachmawati, Kinoshita, 
& Nihira, 2013), we succeeded in creating C. militaris 
transformant through heterologous expression 
by introducing laeA gene to discover newly 
produced bioactive compounds. The transformants 
successfully produced new and/or enhanced peaks 
indicating the enhanced production of metabolites. 
The next step that is reported in this article is the 
structure elucidation of the compounds. The aim of 
this research was to search for newly produced or 
enhanced bioactive compounds production of C. 
militaris using genetic engineering.
MATERIALS AND METHODS
Time and Place of the Research
The research was conducted on October 
2009-July 2011 in the Laboratory of Molecular 
Microbiology, Division of Advanca Biotechnology, 
Graduate School of Engineering, Osaka University 
Japan.
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Reproducibility Analysis of Secondary 
Metabolite
In the previous research (Rachmawati, 
Kinoshita, & Nihira, 2013) metabolites profiling 
by HPLC analysis were performed in all LaeA 
transformant to determine the effect of LaeA. 
Among all eight LaeA transformants, transformants 
encoded with 3F produced two notable peaks 
under A3M medium condition supplemented 
with Sanagiko. To check the reproducibility of the 
compounds, same culture condition were used to 
cultivate 3F transformant, under shaking condition 
(28 oC, 120 spm). After 14 days, the mycelia of 
the cultures were extracted with half volume of 
acetone. The mixtures of broth were centrifuged 
to separate the solvent layers from the aqueous 
layers. In vacuo evaporation were conducted 
with one millilitre solvent layer that were being re-
dissolved in 1 mL DMSO and filtered with a 0.2 µm 
Polytetrafluoroethylene (PTFE) filter (Advantec, 
Japan).
HPLC coupled with DAD analysis were 
conducted using 100-μl transformant extract. 
HPLC system used was an Agilent HP1100 with 
a photodiode array detector (200-600 nm) using 
Rainin Microsorb C18 (4.6 x 75 mm) column. A 
stepwise gradient of CH3CN-0.15 % KH2PO4 (pH 
3.5) (15 %-85 % v/v) were used as the mobile phase, 
with 1.2 mL per minute flow rate. The condition for 
the gradient were 15 % (0-3 minutes), 15-40 % 
(3-6 minutes), 40 % (6-12 minutes), 40-55 % (12-
19 minutes), 55-85 % (19-22 minutes), 85%(22-29 
minutes), and 85-15 % (29-32 minutes). 
Purification of Target Compounds
Purification of target peaks was started by 
making large-scale cultivation involving 16 flasks of 
30 ml culture in 100 ml Erlenmeyer flasks (total 480 
ml) and 6 flasks of 100 ml culture in 500 ml baffle 
flasks (total 600 ml). From the 480 ml culture, 2.19 
g of crude extract was obtained; and from 600 ml 
culture, 2.6 g of crude extract was obtained. This 
crude extract was further purified.
The extraction of the mycelium and 
fermentation broth was conducted in transformant 
3F after 7 days fermentation. Half-volume of 
n-butanol were added to the broth and stirred for 
one hour. The extract were then being centrifuged to 
separate the mixture, continued with separation of 
organic layer from the aqueous layer in an extraction 
funnel, and being dried with anhydrous Na2SO4. 
The reversed-phase C-18 column chromatography 
were used to further purify the crude extract, with a 
step gradient of hexane and ethyl acetate with the 
ratio of 10:0, 9:1, 8:2, 7:3, 6:4, 5:5, 4:6, 3:7, 2:8, 
1:9, and 0:10 using Sep-Pak© Vac 35 cc (10 g) C18 
cartridge (Waters, USA). Target compound was 
completely eluted in 90 % and 100 % ethyl acetate 
(fraction 10 and 11 respectively). Final purification 
was conducted by subjecting fractions  10-11  to 
reversed-phase  HPLC with 80 % methanol + 0.1 % 
TFA to yield purified target compounds.
To further purify the target compound, 0.2 
g of crude extract were used to be separated by 
column chromatography using Sep-Pak Silica 35 cc 
column. The solvent used as mobile phase were a 
mixture of hexane and ethyl acetate respectively. 
After checking with HPLC-DAD, it was revealed that 
the target compound was eluted in 90 % and 100 % 
ethyl acetate (fraction 10 and 11, respectively). The 
target compounds in this fraction were collected 
by HPLC, and yielded 37.31 mg and 20.63 mg for 
compound 1 and compound 2, respectively. These 
purified compounds were sent to mass spectrometry 
to gain the information about the molecular weight. 
Structure Elucidation of Target Compounds
Before being subjected to structure 
elucidation, HPLC analysis on an Agilent HP-
1100 system were conducted to yield the target 
compounds, using a Cosmosil 5C18-AR-II column 
(Nacalai Tesque Inc., 4.6 x 100 mm), with methanol 
as the solvent, unless otherwise stated.
The purified compounds obtained from 
fraction 1:9 and 0:10 of hexane and ethyl acetate 
were analysed by mass spectrometry (HRFABMS 
using JEOL JMS-700 spectrometer) and their 
structures were elucidated by proton Nuclear 
Magnetic Resonance (NMR) (400 MHZ, using JEOL 
JNM-ECP 400 spectrometer) in CDCl3.
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RESULTS AND DISCUSSION
Reproducibility Analysis of Secondary 
Metabolite
In the previous research (Rachmawati, 
Kinoshita, & Nihira, 2013) metabolites profiling 
by HPLC analysis were performed in all LaeA 
transformants to determine the effect of LaeA towards 
the production of secondary metabolite. Among all 
eight LaeA transformants, transformants encoded 
with 3F produced two notable peaks, indicating two 
newly production of compounds. The reproducibility 
analysis proved that these peaks were reproducible 
under A3M medium condition supplemented with 
insect derived materials Sanagiko. The similar 
peaks were not detected in the wild-type strain 
(Fig.1). First compound, designated as compound 
1, were eluted at 24.9 min with λmax: 210 nm and 
absorbent for UV Spectrum. Compound 2 were 
eluted at 25.8 min and has similar UV spectrum.
By comparing the position of eluted 
compounds in the HPLC condition and the UV 
spectra with those registered in-house compounds 
database, compound 1 and compound 2 has strong 
possibility to be derivatives of beauvericin, a common 
compound within genus Isaria, the teleomorph form 
of Cordyceps (Luangsa-Ard, Berkaew, Ridkaew, 
Hywel-Jones, & Isaka, 2009). Since compound 1 
and beauvericin overlapped completely in HPLC 
when co-injected, compound 1 was assumed to 
be beauvericin itself or closely related compound 
to beauvericin. To further confirm this assumption, 
mass spectrometry analysis were performed to both 
compounds. Subsequently the molecular weight 
of both compounds were estimated by HRFAB-
MS. MS spectra reveals that compound 1 has the 
same molecular weight as beauvericin (783.4), 
while compound 2 has molecular weight 797.4, 
suggesting the presence of additional methylene 
(CH2) group in the compound (Fig.2).
To obtain further information of compound 
1, both compound 1 and beauvericin standard 
were subjected to HREI-MS analysis to compare 
their fragmentation pattern. It was found that 
compound 1 has the same fragmentation pattern 
with beauvericin (C45H57N3O9). Since the pattern of 
fragmentation of compound 1 is almost identical to 
that of beauvericin, it is being strongly suggested 
that compound 1 might be beauvericin (Fig.3).
Beauvericin contains three N-methyl-L-
phenylalanyl and D-a-hydroxy-isovaleryl residues 
in alternating sequence. At least 15 analogs of 
beauvericin have so far been reported, and each 
analog of beauvericin possesses molecular weight, 
ranging from 735-837. The molecular weight of 
compound 1 and compound 2 were being compared 
with that of beauvericin and its reported analogs. 
Among the reported beauvericin and beauvericin 
analogs, compound 1 has the same molecular 
weight only with beauvericin itself, while compound 
2 possesses the same molecular weight with that of 
beauvericin A and beauvericin F (Table 1).
Fig. 1. HPLC profile of newly emerged compounds in LaeA transformant 3F from C. militaris HF 374-1 
strain. A) Peaks production of wild type (3WT) strain is shown in upper chart, and of the transformant 3F is 
shown in below part. B) UV spectrums of each compound produced by transformant 3F.
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Fig. 2. Molecular weight of compound 1 and compound 2 from laeA transformant and comparison with 
beauvericin
Fig. 3. Comparison of fragmentation patterns of Compound 1 and beauvericin
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In order to confirm whether compound 1 was 
indeed beauvericin and compound 2 was one of 
known analogs of beauvericin, both compounds 
were subjected to Nuclear Magnetic Resonance 
(NMR) analysis by proton-NMR in 400 MHz in CDCl3. 
With this partial structure elucidation, the proton 
signal of both signals could be determined. The 
NMR spectra revealed that compound 1 missed one 
methyl signal, but acquired a double-doblet signal, 
different from beauvericin, but was still indicating 
that compound 1 might be beauvericin (Table 2).
Since compound 2 has the same molecular 
weight with beauvericin A and beauvericin F, we 
decided to compare the proton signal of compound 2 
with those two analogs of beauvericin. Interestingly, 
from the comparison result of proton-NMR spectra 
among those compounds, it was demonstrated that 
compound 2 was not identical neither to beauvericin 
A nor beauvericin F, indicating that compound 2 
might be an unknown analog of beauvericin (Table 
3). Further structure elucidation by carbon MNR 
and two-dimensional NMR is needed to reveal the 
chemical structure of compound 2.
Beauvericin was originally isolated from the 
well-known EF Beauveria bassiana. The fungus 
B.bassiana is the most widely distributed species 
of the genus and is generally found on infected 
insects both in temperate and tropical areas 
throughout the world (Zimmermann, 2007). One 
of the most important compounds produced by B. 
bassiana is beauvericin which showed insecticidal 
and antibacterial activity. Beauvericin is a cyclic 
hexadepsipeptide comprised of three molecules 
of N-methyl phenylalanine and three molecules 
of 2-hydroxyisovaleric acid, and has symmetrical 
structure. The structural feature of beauvericin is 
attractive because it is capable of accepting several 
precursors that would lead to the biosynthesis 
of many ―unnatural- natural products in a single 
fermentation (Isaka, Kittakoop, Kirtikara, Hywel-
Jones, & Thebtaranonth, 2005).
Unlike the other species of Cordyceps, there 
is not many reports on the secondary metabolite 
being produced by C. militaris. The most studied 
compound from this EF is cordycepin, that possesses 
antifungal, antivirus, and antitumor activities. This 
compound also is being reported to have potential 
and interesting biological and pharmacological 
activities, e.g. anti-cancer, anti-virus, anti-infection, 
and immunological stimulating activities.
Table 1. List of molecular weights of beauvericin, beauvericin analogs, compound 1, and compound 2
Name Molecular Weight
Molecular 
Formula Name
Molecular 
Weight
Molecular 
Formula
Beauvericin 783 C45H57N3O9 allobeauvericin C 825 C48H63N3O9
beauvericin A 797 C46H59N3O9 beauvericin G1 769 C44H55N3O9
beauvericin B 811 C47H61N3O9 beauvericin G2 755 C43H53N3O9
beauvericin C 825 C48H63N3O9 beauvericin G3 741 C42H51N3O9
beauvericin D 769 C44H55N3O9 beauvericin H1 801 C45H56FN3O9
beauvericin E 735 C41H57N3O9 beauvericin H2 819 C45H55F2N3O9
beauvericin F 797 C46H59N3O9 beauvericin H3 837 C45H54F3N3O9
allobeauvericin A 798 C46H59N3O9 compound 1 783 C45H57N3O9
allobeauvericin B 811 C47H61N3O9 compound 2 797 C46H59N3O9
Table 2. The Proton signal of beauvericin and compound 1
beauvericin (Ref.) beauvericin (Standard) Compound 1
0.42, d, CH3 0.375,d
0.79, d, CH3 0.789, d 0.75, d
0.86, d
2.03, m, β-CH, hiv 1.96, m 1.24, s
1.67, m
2.98,s, N-CH3 3.008, s 3.026,s
2.96, m. β-CH(H), phe 2.97, m 2.96,s
3.34, dd, β-CH(H), phe 3.42, m 3.52, dd
4.93, d, α-CH,hiv 4.85, d
5.42, dd, α-CH,phe 5.56, m 5.05, m
5.75, dd
7.23, m, aromatic H, phe 7.23, m 7.24, m
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The other bioactive compounds found in 
this EF are three new-10 memberedmacrolides, 
cepharosporolides, and pyridine-2,6-dicarboxylic 
acid (Rukachaisirikul, Pramjit, Pakawatchai, 
Isaka, & Supothina, 2004). Those huge potential 
of cordycepin makes C. militaris an economically 
important fungi, and its potential bioactive 
compounds are believed yet to be fully explored. 
The finding about newly produced beauvericin in 
this fungus when is regulated by global regulator 
LaeA opened up the potential for highly valuable 
secondary metabolite production.
Other than in B. bassiana, production of 
beauvericin also was reported in soil-borne fungal 
pathogens Fusarium oxysporum. This ascomycete 
that can attack 100 various crop relies on beauvericin 
as its virulence factor. López-Berges et al. (2013) 
found that velvet protein complex regulates the 
fungal development and production of secondary 
metabolite including beauvericin in this fungus. 
Velvet protein is a complex protein consists of VeA, 
VelB, VelC, and LaeA. VeA and LaeA were also 
found to be responsible for the full virulence of F. 
oxysporum. This report emphasizes the importance 
of LaeA in the survivorship of various filamentous 
fungi.
The previous study proved that the enrichment 
of LaeA in the genome of C. militaris effectively 
enhance the production of secondary metabolite 
in this EF. LaeA were proved to regulate the 
production of both new and enhanced compounds 
in eight C. militaris transformants. In this report 
we only focused on one transformant (strain HF 
374) that produced significant number production 
of new compounds that is not detected in the wild 
type. Nevertheless, the other laeA transformants 
that produced reproducible compounds wait to be 
elucidated. This study confirmed that one of the 
bioactive compound produced by the transformant 
is beauveria, the essential virulence factor for 
controlling insect pest. As for the other compound 
has potential to be new analog of beauveria.
CONCLUSION 
Eights newly emerged compounds have 
reproducibly been observed in the culture of three 
LaeA transformants, transformants 3F and 3H (from 
HF 374-1), and 0C (from CM 001-5). Among these 
8 compounds, compound 1 and compound 2 were 
significantly highly and reproducibly produced, and 
therefore were chosen as primary target compounds 
to be elucidated their structure.
Compound 1 and compound 2, possesses 
similar physico-chemical properties with beauvericin 
or its reported analogs. Based on 1H-NMR analysis, 
compound 1 proved to be beauvericin, as for 
compound 2 proved to be different from the reported 
ones, suggesting that those two compounds might 
be new analogs of beauvericin.
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